Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly P Burke

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Experimental Medicine|July 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashionKristen E Pauken, Samuel C Markson, Thomas S Conway, et al.
Nature Immunology|January 13, 2026
Stability and progressive differentiation of T<sub>FR</sub> cells are intrinsically and extrinsically controlled by T<sub>FH</sub> programsJeong-Mi Lee, Paulo Lisboa Raeder, Ridwan B Rashid, et al.
The Journal of Experimental Medicine|March 2, 2021
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichmentKristen E Pauken, Osmaan Shahid, Kaitlyn A Lagattuta, et al.
Science Advances|April 13, 2022
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancerMohamed S Hasim, Marie Marotel, Jonathan J Hodgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
Nature Communications|September 1, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanomaJiekun Yang, Cassia Wang, Doris Fu, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanomaTyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomasAmy Y Huang, Kelly P Burke, Ryan Porter, et al.
Cancer Cell|March 12, 2021
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A Braun, Kelly Street, Kelly P Burke, et al.
Nature Medicine|March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancerMeng Xiao He, Michael S Cuoco, Jett Crowdis, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Experimental Medicine|July 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashionKristen E Pauken, Samuel C Markson, Thomas S Conway, et al.
Nature Immunology|January 13, 2026
Stability and progressive differentiation of T<sub>FR</sub> cells are intrinsically and extrinsically controlled by T<sub>FH</sub> programsJeong-Mi Lee, Paulo Lisboa Raeder, Ridwan B Rashid, et al.
The Journal of Experimental Medicine|March 2, 2021
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichmentKristen E Pauken, Osmaan Shahid, Kaitlyn A Lagattuta, et al.
Science Advances|April 13, 2022
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancerMohamed S Hasim, Marie Marotel, Jonathan J Hodgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
Nature Communications|September 1, 2025
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanomaJiekun Yang, Cassia Wang, Doris Fu, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanomaTyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomasAmy Y Huang, Kelly P Burke, Ryan Porter, et al.
Cancer Cell|March 12, 2021
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A Braun, Kelly Street, Kelly P Burke, et al.
Nature Medicine|March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancerMeng Xiao He, Michael S Cuoco, Jett Crowdis, et al.
Pageof 3